Work

Adverse Drug Reactions: Building Drug Safety Beyond Marketing Authorisation

Year: 2026

Type: article

Abstract: Marketing authorisation is a regulatory conclusion that, on the basis of the available evidence, the medicine has a favourable benefit-risk balance for a defined population and indication [...].

Source: Journal of Clinical Medicine

DOI: 10.3390/jcm15186994

Authors: Andrej Belančić, Ivana Mudnić

Institutions: University of Rijeka, University of Split

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,137

OpenAlex ID: W7212150919

FWCI:

Cites: 22

Cited by:

Related to: